On this page
Tofacitinib (brand name Xeljanz) is a tablet for ulcerative colitis (UC). It belongs to the same group of medicines as upadacitinib, called JAK inhibitors, and was the first of them to be used in inflammatory bowel disease (IBD). It is not used for Crohn's disease.
How does it work?
Inside immune cells, enzymes called Janus kinases (JAKs) pass on the signals from chemical messengers that drive inflammation. Tofacitinib blocks some of these enzymes, which damps down the inflammation. Because it is a small molecule rather than a protein, it can be taken as a tablet, and the body doesn't make antibodies against it.
What is it used for?
Moderate to severe UC that hasn't responded to, or can't be treated with, other medicines, which may include steroids, immunosuppressants and biologics.
Because of the safety warnings below, it is used with extra care, or only if there is no suitable alternative, in people aged 65 or over, people who smoke or used to smoke for a long time, and people with a higher risk of heart disease, blood clots or cancer.
Before you start
You will have blood tests, including a blood count, liver tests and cholesterol, and checks for tuberculosis (TB), hepatitis B and C and HIV. The non-live shingles vaccine is often recommended before you start, because shingles is more common with JAK inhibitors. Tell your team if you have had blood clots, heart disease or cancer.
How is it taken?
- Starting dose: 10 mg twice a day for 8 weeks (sometimes up to 16 weeks).
- Then: usually 5 mg twice a day. Some people need to stay on 10 mg twice a day; your team will use the lowest dose that keeps your colitis under control.
Take the tablets at about the same times each day, with or without food. Many people notice an improvement within days to a couple of weeks.
Some medicines affect tofacitinib levels, including certain antifungals and the antibiotic rifampicin, so always tell your doctor or pharmacist that you take it.
Blood tests
You will have blood tests regularly, especially in the first few months, to check your blood count, liver and, after about 8 weeks, your cholesterol.
Side effects
Common:
- Colds, sore throat and other infections of the nose, throat and chest
- Raised cholesterol
- Headache, diarrhoea or feeling sick
- Rash
- Changes in blood counts or liver tests, found on routine blood tests
- Shingles, a painful, blistering rash, usually on one side of the body. Contact your GP or team promptly if you get it, as early treatment helps.
Infections. Tofacitinib can make it harder to fight infections, and serious infections can occur. Contact your team or GP if you have a fever or feel unwell, and tell them you take tofacitinib.
Important safety warnings
In a large study of people with rheumatoid arthritis aged 50 or over with at least one heart risk factor, tofacitinib was linked to a higher risk of heart attacks and strokes, blood clots, some cancers and serious infections than anti-TNF medicines. Blood clots in the lungs were more common at the higher dose of 10 mg twice a day. These warnings apply to all JAK inhibitors.
Seek medical help straight away if you have:
- Chest pain or tightness, or sudden breathlessness
- Pain, swelling or redness in one leg
- Sudden weakness or numbness on one side, slurred speech or a drooping face
Vaccinations
Don't have live vaccines shortly before or while taking tofacitinib. Non-live vaccines are safe and recommended, including the yearly flu injection, COVID-19, pneumococcal and the non-live shingles vaccine.
Pregnancy and breastfeeding
Tofacitinib must not be taken during pregnancy. If you could become pregnant, use effective contraception while taking it and for at least 4 weeks after the last dose. If you become pregnant, or want to, talk to your IBD team straight away so they can switch you to a medicine suitable in pregnancy. Don't breastfeed while taking it.
See Pregnancy and Inflammatory Bowel Disease.
Surgery and travel
Tell your surgeon or dentist that you take tofacitinib; you may be asked to pause it around an operation. Take enough tablets for your whole trip in your hand luggage. See Travel Insurance with Crohn's or Colitis.
If tofacitinib does not work
Other options include biologic medicines such as vedolizumab, ustekinumab or an anti-TNF, another tablet such as ozanimod, and surgery. See Medicines for Crohn's Disease and Ulcerative Colitis and Treatment of Ulcerative Colitis.
Never stop tofacitinib without discussing it with your IBD team first.